spacer

CDC HomeHIV/AIDS > Topics > Testing > Rapid HIV Testing > CDC Studies of Rapid HIV Testing

space HIV Testing
space
arrow Trends
space
arrow Challenges
space
arrow CDC Response
space
arrow Rapid HIV Testing
space
arrow Healthcare Settings
space
arrow Questions & Answers
space
arrow Fact Sheets
space
arrow Slide Sets
space
arrow Podcasts
space
arrow Reports
space
arrow Recommendations & Guidelines
space
arrow Bibliography
space
arrow Links
space
 
LEGEND:
PDF Icon   Link to a PDF document
Non-CDC Web Link   Link to non-governmental site and does not necessarily represent the views of the CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
spacer spacer
spacer
Skip Nav spacer
Rapid HIV-1 Diagnostic Algorithms for Use in HIV Infection Screening
spacer
spacer

E. Calero1, J. Malia1, R. Sawyer2, L. Brown3, D. Birx1, B. Branson4, N.Michael1.
1Walter Reed Army Institute of Research and 2Henry M. Jackson Foundation, Rockville, MD, 3Walter Reed Army Medical Center, Wash D.C., 4Centers for Disease Control and Prevention, Atlanta, GA

Background: Recent world events underscore the need for rapid HIV screening techniques, because of both acute demands for blood products that exceed the screened supply and exposures to blood of unknown HIV status during rescue efforts. Clinics that support prevention and counseling also frequently lack the testing capacity to quickly provide HIV screening results. Existing HIV serodiagnostic techniques (EIA/Western blot) are too cumbersome to rapidly screen for HIV infection.

Methods: We compared the performance of an algorithm using three newer, unlicensed HIV rapid test devices--Hemastrip (H)(ChemBio Diagnostic Systems), Multispot (M)(BioRad Laboratories), and Oraquick (O)(OraSure Technologies)--with results of conventional EIA/Western blot. These 3 devices were selected based on their previously demonstrated high sensitivity, specificity, and ease of use. We conducted a retrospective, masked study of 439 archived serum specimens (411 HIV-1 negative and 28 HIV-1 positive as determined by EIA/Western blot). All sera were screened in parallel with three combinations of two rapid devices used together (MO, MH, OH). Concordantly nonreactive samples were coded as nonreactive while concordantly reactive or discordant samples were tested with the third device. Final results were based on ”best of three” rapid test results for all three combinations (MO-H, MH-O, OH-M).

Results: All three rapid test combinations yielded 100% sensitivity and specificity compared with EIA/Western blot. 7 samples with initially discordant rapid tests were correctly resolved as reactive by the third rapid test.

Conclusions: The accuracy of combinations of HIV rapid tests used in a parallel algorithm is comparable to that of EIA/Western blot. These rapid devices could be used in civil-military emergencies or in prevention and counseling clinics to provide rapid and accurate HIV diagnosis.

Presented at XIV International AIDS Conference, July 7-12, 2002, Barcelona, Spain

spacer
Last Modified: September 20, 2006
Last Reviewed: September 20, 2006
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
spacer
spacer CDC Black Logospacer Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
spacer
spacerHHS Logo